CN109260090A - A kind of eye cream composition and preparation method thereof - Google Patents
A kind of eye cream composition and preparation method thereof Download PDFInfo
- Publication number
- CN109260090A CN109260090A CN201811362917.0A CN201811362917A CN109260090A CN 109260090 A CN109260090 A CN 109260090A CN 201811362917 A CN201811362917 A CN 201811362917A CN 109260090 A CN109260090 A CN 109260090A
- Authority
- CN
- China
- Prior art keywords
- eye cream
- extract
- cream composition
- eye
- kayexalate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8117—Homopolymers or copolymers of aromatic olefines, e.g. polystyrene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a kind of eye cream compositions and preparation method thereof, eye cream composition includes the ingredient of following weight percent: the deionized water of kayexalate 8~20%, ditch pelvetia silquosa extract 0.3%~5%, 2~8%, 1,3 butanediol 3~8% of apple berry extract, methyl hydroxybenzoate 0.05~0.25%, Sodium Hyaluronate 0.03~0.15%, hydroxypropyl starch phosphate 10~15%, glycosphingolipids 2~8%, Phenoxyethanol/Sensiva SC50 0.2~1% and surplus.The present invention is added to kayexalate and ditch pelvetia silquosa extract, apple berry extract, dermal tissue can effectively be penetrated into, more quickly improve the collagen structure of skin corium, enhancing eye circumference skin elastic simultaneously improves dry, relaxation, repair impaired or innutritive cell, it is obvious to continue skin aging, and effect is better than addition one of which or two kinds of ingredients.
Description
Technical field
The present invention relates to cosmetic technical field, it is specifically related to a kind of eye cream composition and preparation method thereof.
Background technique
Eyes are the positions of facial skin loose aging earliest.The part of human eye is two holes, without skeletal support,
Skin is also very thin, only the 1/4 of cheek skin thickness, and sebaceous glands and sweat gland distribution are also seldom, while lacking abundant muscle layer,
Only a thin layer of cricoid muscle, is called orbicular muscle of eye.It is exactly so fragile position is most busy most active in face
, it not only to blink daily about 10000 times, also continually to cooperate the facial expressions activity such as smiled, frowned.Under eye circumference
Along also distributed many important lymph nodes, once Lymphatic Circulation is bad to form waste, waste water accumulation at the position, cause
Skin histology is loose, skin texture is coarse, forms eye pouch and black eye.The thin only 0.5mm of eye circumference skin, daily averagely blink 10,000
It is secondary, in addition the acquired dispositions such as excess eye-using, so that there is aging ahead of time in eye skin.The eye pouch of stereotype is no longer the elderly
Patent, the trend of eye pouch race rejuvenation is more and more obvious, and just has within even 25 years old an eye pouch generation, including Ye Mao race, stay up late
Race, the office worker for being often used computer etc. are that eye pouch does sth. in advance the object knocked at the door because excessive eye uses.
Eye cream, one of skin type cosmetic product.There is moist effect, other than it can lower black eye, eye pouch problem, simultaneously
Also has the effect of improving wrinkle, microgroove.Eye cream is for protecting around eyes than this layer of relatively thin skin.Eye cream is to eye
Bag, black eye, crow's feet etc. have certain effectiveness, but be different eye cream play the role of it is different.There are many type of eye cream, greatly
Cause is divided into eye mask, eye glue, eye gel, eye sticker, eye cream etc.；Functionally be divided into moist eye cream, consolidation eye cream, moisturizing eye cream,
Anti-aging eye cream, antiallergic eye cream etc..There are many products for being used for eye-care currently on the market, various in style, but universal
There are poor permeability, be not easy to absorb, the problems such as using effect is unobvious fruit.
Summary of the invention
It is an object of the invention to overcome the above problem and provide a kind of eye cream composition and preparation method thereof, the eye cream energy
Dermal tissue is effectively penetrated into, the collagen structure of skin corium is more quickly improved, enhance eye circumference skin elastic and improves dry, relaxation
Phenomenon repairs impaired or innutritive cell, hence it is evident that continue skin aging.
To achieve the above object, the technical solution adopted by the present invention is that a kind of eye cream composition, including polystyrolsulfon acid
Sodium and plant extracts, the plant extract include ditch pelvetia silquosa extract, apple berry extract.
Kayexalate of the invention forms transparent, flexible film, and shrinks when dry, guides rapidly
Electrostatic.It, which forms a film, also has high-temperature stability, is resistant to the high temperature more than 300 C.Its film forming characteristics have compact skin,
The effect of smooth wrinkle.
Ditch pelvetia silquosa extract: rich in the glucides such as L- trehalose, mannitol and volemitol and several amino acid at
Point, there is moisturizing, softening skin, remove free radical, crease-resistant, firm skin and increase the multiple efficacies such as skin elasticity.
Apple berry extract: from the organic Ah slave's card apple of Italy, there is potent anti-freedom in different cell levels
Base and oxidation resistance, and the DNA of cell can be protected from oxidative pressure.
Present inventor's discovery, kayexalate and ditch pelvetia silquosa extract, apple berry extract are answered
Match, there is the synergistic function for reducing eye wrinkle-removing.
Preferably, the weight ratio of the kayexalate and plant extracts is 8~20:2.3~13.
In eye cream composition of the present invention, constituent content will affect effect, the study found that described in kayexalate
Within the scope of ditch pelvetia silquosa extract, the preferred weight proportion of apple berry extract, the present invention is imitated with significant eye anti-wrinkle
Fruit.
Preferably, the weight ratio of the kayexalate and plant extracts is 10~16:5~10.Eye of the present invention
In cream composition, within the scope of the preferred weight proportion, anti-wrinkle better effect of the present invention.
Preferably, the weight ratio of the kayexalate and plant extracts is 16:8.Present inventor passes through
Lot of experiments discovery, in kayexalate situation identical with the total additive amount of plant extracts, the ingredient
Weight ratio will affect anti-wrinkle effect, and found by lot of experiments, kayexalate and plant extracts ingredient
Herein under specific weight ratio, anti-wrinkle effect is preferable.
Preferably, the weight ratio of the ditch pelvetia silquosa extract and apple berry extract is 0.3~5:2~8.Preferably,
The weight ratio of ditch pelvetia silquosa extract and apple berry extract is 1~4:4~6.Present inventor's discovery, ditch pelvetia silquosa extract
The weight ratio of object and apple berry extract also will affect anti-wrinkle effect, studies have shown that in this particular range, anti-wrinkle effect compared with
It is good.Preferably, the weight ratio of ditch pelvetia silquosa extract and apple berry extract is 1:3.Especially when ditch pelvetia silquosa extract with
The weight ratio of apple berry extract is that its anti-wrinkle effect of 1:3 is best.
Preferably, the kayexalate is 8~20%, plant extracts in the weight percent of eye cream composition
It is 2.3%~13% in the weight percent of eye cream composition；Preferably, the ditch pelvetia silquosa extract is in eye cream composition
Weight percent is 0.3%~5%, apple berry extract in the weight percent of eye cream composition is 2~8%.
Preferably, the eye cream composition further includes the ingredient of following weight percent: 1,3 butanediol 3~8%, oxybenzene
Methyl esters 0.05~0.25%, Sodium Hyaluronate 0.03~0.15%, hydroxypropyl starch phosphate 10~15%, glycosphingolipids 2~
8%, the deionized water of Phenoxyethanol/Sensiva SC50 0.2~1% and surplus.
Hydroxypropyl starch phosphate can co-emulsifier be stable, it is beautiful to increase and establishes viscosity.Contain STRUCTURE XL
Emulsification with can within the scope of broad temperature (- 30 DEG C to 50 DEG C) there is fabulous stability.It also gives formula band simultaneously
Come solid sense and good skin sense.Its nonionic and wide compatibility give the great flexibility of formulator to cope with width
Wide pH and high content of salt (including monovalence, divalent ion system, up to 20%) and brought by various other raw material match
Side's challenge.
Preferably, the eye cream composition includes the ingredient of following weight percent: kayexalate 16%, ditch deer
Angle dish extract 2%, apple berry extract 6%, 1,3 butanediols 5%, methyl hydroxybenzoate 0.12%, Sodium Hyaluronate 0.1%, hydroxyl
The deionized water of propyl starch phosphate 13%, glycosphingolipids 4%, Phenoxyethanol/Sensiva SC50 0.5% and surplus.This
Application inventors be surprised to learn that, each ingredient of the eye cream composition is herein under specific weight percent, to the wrinkle of eye
Line, which is reduced, has significant effect.
Beneficial effects of the present invention: the present invention is added to kayexalate and mentions with ditch pelvetia silquosa extract, Apples
Object is taken, dermal tissue can be effectively penetrated into, more quickly improve the collagen structure of skin corium, enhance eye circumference skin elastic and is improved dry
Dry, relaxation repairs impaired or innutritive cell, hence it is evident that continues skin aging, and effect is one of better than addition
Or two kinds of ingredients.
Detailed description of the invention
Fig. 1 is the eye anti-wrinkle test result figure of eye cream composition of the invention；
Fig. 2 is the eye anti-wrinkle test result figure of the formula (one) of the embodiment of the present invention 8；
Fig. 3 is the eye anti-wrinkle test result figure of the formula (two) of the embodiment of the present invention 8.
Specific embodiment
To better illustrate the object, technical solutions and advantages of the present invention, below in conjunction with specific embodiment to the present invention
It is described further.
Each raw material involved by following embodiment is commercially available versatile material unless otherwise instructed.
Examples 1 to 6
Examples 1 to 6 is the embodiment of eye cream composition of the invention, the weight percentage of the eye cream of Examples 1 to 6
Formula is shown in Table 1:
The formula of 1 Examples 1 to 6 eye cream composition of table
1) preparation method of eye cream composition of the invention is the following steps are included: propose 1,3 butanediols, methyl hydroxybenzoate component
Before be pre-dissolved；2) deionized water, 1,3 butanediols, methyl hydroxybenzoate, Sodium Hyaluronate, hydroxypropyl starch phosphate are sequentially added into cream
Change pot, be warming up to 80-85 degree, opens homogeneous, stir evenly；3) 65 degree are dropped to temperature, kayexalate is added and is continued
Stirring cooling；4) 45 degree are down to temperature, by ditch pelvetia silquosa extract, apple berry extract, glycosphingolipids, Phenoxyethanol/second
Base hexyl glycerol sequentially adds, and stirs evenly, discharging.
Comparative example 1~6
The eye cream formula of comparative example 1~6 is shown in Table 2:
The formula of 2 comparative example of table, 1~6 eye cream composition
The measure of merit of 7 eye cream composition of embodiment
Test sample: 1~6 sample of sample and comparative example of Examples 1 to 6；
Subject: 140 40-50 years old age women are equally divided into A, B, C, D, E, F, G, H, I, G, K, L, M, N group,
Every group of 10 people；
Test equipment: VISIA skin detection instrument；
Test zone: circumference of eyes；
Test method: blank group is without any processing.Sample is uniformly applied to the amount of mung bean size by other groups daily
Eye circumference is enclosed, and obtains test result after 4 weeks.
Conceptual design: 0 week: blank group (A group) personnel were without any processing.B group smears the sample of embodiment 1, and C group is smeared
The sample of embodiment 2, D group smear the sample of embodiment 3, and E group smears the sample of embodiment 4, and F group smears the sample of embodiment 5,
G group smears the sample of embodiment 6, and H group smears the sample of comparative example 1, and I group smears the sample of comparative example 2, and J group smears comparative example 3
Sample, K group smear comparative example 4 sample, L group smear comparative example 5 sample, M group smearing comparative example 6 sample, N group smearing
Commercially available product, test carry out eye wrinkle-removing number to sample application area after starting and carry out parametric measurement.
Evaluation method: after sample uses 1 week, 2 weeks, 3 weeks, 4 weeks, the eye wrinkle-removing quantity of each group personnel application area is compared
Difference, evaluate its anti-wrinkle effect.As a result as shown in table 3 and Fig. 1:
3 eye cream composition test result of table
It can be seen that from table 3 and Fig. 1, eye cream composition prepared by the embodiment of the present invention 1~6 is relative to blank group, eye
Portion's wrinkle decrease rate is on the rise, and wrinkle is significantly reduced, and wherein most significant with the reduction of the wrinkle of embodiment 1, implements
Example 1 the difference is that only that comparative example 1~5 has lacked kayexalate, ditch deer respectively compared with comparative example 1~5
Angle dish extract and apple berry extract is one such or two or three of ingredient, and as can be known from the results, with 1 phase of embodiment
It is reduced than, significant effect, shows three kinds simultaneously under service condition, better than only using one of, two kinds of effects, and the present invention
Relative to commercially available eye cream product, better effect.
Embodiment 8
The present embodiment further studies the weight of kayexalate, ditch pelvetia silquosa extract and apple berry extract
Influence of the content ratio to anti-wrinkle effect of the invention.Test method is as described in Example 7, and the present embodiment is provided with experimental group a
~l group, every group of formula are shown in Table 4 and table 6, and anti-wrinkle effect is shown in Table 5, Fig. 2 and table 7, Fig. 3.The eye cream group of the present embodiment
It is same as Example 1 to close other compositions described in object.
What plant extracts described in the present embodiment table 4 indicated is answering for ditch pelvetia silquosa extract and apple berry extract
Object is closed, the ditch pelvetia silquosa extract in plant extracts in table 4: the weight ratio of apple berry extract is 1:3.And in table 4
Kayexalate, ditch pelvetia silquosa extract and the total weight percentage additive amount of apple berry extract be 24%.
Kayexalate weight percentage in the present embodiment table 6 is 16%, ditch pelvetia silquosa extract and apple
The total weight percentage of berry extract is 8%.
Table 4 is formulated (one)
| Group | The weight ratio of kayexalate and plant extracts |
| A group | 0.5:1 |
| B group | 0.8:1 |
| C group | 1:1 |
| D group | 1.2:1 |
| E group | 2:1 |
| F group | 2.5:1 |
| G group | 3:1 |
5 eye cream composition test result (one) of table
Table 6 is formulated (two)
7 eye cream composition test result (two) of table
From table 4, table 5 and Fig. 2 it is found that in kayexalate, ditch pelvetia silquosa extract and apple berry extract
Total additive amount is identical, and under ditch pelvetia silquosa extract and the weight ratio same case of apple berry extract, changes polystyrene
The weight ratio that sodium sulfonate and plant extract take, anti-wrinkle effect can also change, the results showed that, when kayexalate and plant
When the weight ratio that extract takes is 2:1, anti-wrinkle effect is best.
It is found that the additive amount in kayexalate is identical and plant extracts adds from table 6, table 7 and Fig. 3
Under dosage same case, only change the weight ratio of ditch pelvetia silquosa extract and apple berry extract, anti-wrinkle effect is also corresponding
Change, the results showed that, when ditch pelvetia silquosa extract and apple berry extract weight ratio are 1:3, anti-wrinkle effect is best.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all in essence of the invention
Within mind and principle, any modification, equivalent substitution, improvement and etc. done be should be included within the scope of the present invention.
Claims (10)
1. a kind of eye cream composition, which is characterized in that including kayexalate and plant extracts, the plant extract packet
Include ditch pelvetia silquosa extract, apple berry extract.
2. eye cream composition according to claim 1, which is characterized in that the kayexalate and plant extracts
Weight ratio be 8~20:2.3~13.
3. eye cream composition according to claim 1, which is characterized in that the kayexalate and plant extracts
Weight ratio be 10~16:5~10.
4. eye cream composition according to claim 1, which is characterized in that the kayexalate and plant extracts
Weight ratio be 16:8.
5. eye cream composition according to claim 1, which is characterized in that the ditch pelvetia silquosa extract and Apples extract
The weight ratio of object is 0.3~5:2~8.
6. eye cream composition according to claim 1, which is characterized in that ditch pelvetia silquosa extract and apple berry extract
Weight ratio is 1~4:4~6.
7. eye cream composition according to claim 1, which is characterized in that the weight of ditch pelvetia silquosa extract and apple berry extract
Than for 1:3.
8. eye cream composition according to claim 1, which is characterized in that the kayexalate is in eye cream composition
Weight percent be 8~20%, plant extracts in the weight percent of eye cream composition is 2.3%~13%；Preferably,
The ditch pelvetia silquosa extract is 0.3%~5%, apple berry extract in eye cream combination in the weight percent of eye cream composition
The weight percent of object is 2~8%.
9. eye cream composition according to claim 8, which is characterized in that the eye cream composition further includes following weight hundred
Divide the ingredient of ratio: 1,3 butanediols 3~8%, methyl hydroxybenzoate 0.05~0.25%, Sodium Hyaluronate 0.03~0.15%, hydroxypropyl
Starch phosphate 10~15%, glycosphingolipids 2~8%, Phenoxyethanol/Sensiva SC50 0.2~1% and surplus deionization
Water.
10. eye cream composition according to claim 1, which is characterized in that the ingredient including following weight percent: polyphenyl
Vinyl sulfonic acid sodium 16%, ditch pelvetia silquosa extract 2%, apple berry extract 6%, 1,3 butanediols 5%, methyl hydroxybenzoate 0.12%,
Sodium Hyaluronate 0.1%, hydroxypropyl starch phosphate 13%, glycosphingolipids 4%, 0.5% and of Phenoxyethanol/Sensiva SC50
The deionized water of surplus.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811362917.0A CN109260090B (en) | 2018-11-15 | 2018-11-15 | Eye cream composition and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811362917.0A CN109260090B (en) | 2018-11-15 | 2018-11-15 | Eye cream composition and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN109260090A true CN109260090A (en) | 2019-01-25 |
| CN109260090B CN109260090B (en) | 2021-07-09 |
Family
ID=65189462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811362917.0A Active CN109260090B (en) | 2018-11-15 | 2018-11-15 | Eye cream composition and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109260090B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110420140A (en) * | 2019-07-16 | 2019-11-08 | 广州艾蓓生物科技有限公司 | A kind of eyelid cream and preparation method thereof of dispelling with long-acting eye pouch effect of dispelling |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105687055A (en) * | 2016-03-23 | 2016-06-22 | 广东芭薇生物科技股份有限公司 | Eye repair essence and preparation method thereof |
-
2018
- 2018-11-15 CN CN201811362917.0A patent/CN109260090B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105687055A (en) * | 2016-03-23 | 2016-06-22 | 广东芭薇生物科技股份有限公司 | Eye repair essence and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 无: "Hydroxatone Liftalyze Eye Lifting Serum", 《HTTP://WWW.COSDNA.COM/CHS/COSMETIC_50A2190139.HTML》 * |
| 粉色莲花: "美肌之志（BeautyMate）消除黑眼圈纳米眼部精华素", 《美肌之志（BEAUTYMATE）消除黑眼圈纳米眼部精华素》 * |
| 苹果: "《化妆品植物原料大全》", 30 June 2012, 中国纺织出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110420140A (en) * | 2019-07-16 | 2019-11-08 | 广州艾蓓生物科技有限公司 | A kind of eyelid cream and preparation method thereof of dispelling with long-acting eye pouch effect of dispelling |
| CN110420140B (en) * | 2019-07-16 | 2022-09-27 | 广州艾蓓生物科技有限公司 | Pouch removing cream with long-acting pouch removing effect and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109260090B (en) | 2021-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105748343B (en) | A kind of natural plant extracts composition and its application in cosmetics | |
| CN105147591B (en) | A kind of crease-resistant face cream and preparation method thereof | |
| CN105456051B (en) | A kind of natural moisture preserving face cream | |
| CN110327282A (en) | A kind of dandruff control shampoo containing and preparation process improving scalp epidermis microbial flora | |
| CN110123705B (en) | Moisturizing and anti-wrinkle composition and skin care product | |
| CN111773130A (en) | Hydroxypropyl tetrahydropyrane triol compound and preparation method and application thereof | |
| CN107468582A (en) | One kind is compacted anti-wrinkle eye shadow and preparation method thereof | |
| CN104323927A (en) | Application of mussel adhesive protein in preparing cosmetics for skin beautifying | |
| CN111265439A (en) | Oil-control, dandruff-removing and itching-relieving shampoo and preparation method thereof | |
| CN113750020A (en) | Bubble hair conditioner | |
| CN109350591A (en) | A kind of U.S. face dried noodle film and preparation method thereof | |
| CN109330938A (en) | A kind of composition with senile-resistant efficacy, facial mask and preparation method containing it | |
| CN108451893A (en) | A kind of toner and preparation method thereof with long-acting moisture-keeping efficacy | |
| CN109260090A (en) | A kind of eye cream composition and preparation method thereof | |
| CN109199923A (en) | A kind of atomizing sleep mask and preparation method thereof | |
| CN107854358A (en) | A kind of anti-apolexis composition and the skin care item containing said composition | |
| CN102188330B (en) | Use of bacterial cellulose wet membrane in hair-care products | |
| CN107822939A (en) | A kind of potent moisturiser and preparation method thereof | |
| CN110151569A (en) | A kind of moisturizing beauty essence and preparation method thereof | |
| KR102429344B1 (en) | A cosmetic composition for anti-dandruff comprising extract of Polygala tenuifolia or Lycium chinense | |
| JPS62289509A (en) | Hair cosmetic | |
| CN104473784B (en) | A kind of fuel-displaced massage cream and preparation method thereof | |
| KR100454149B1 (en) | Hair-Care composition containing Porifera extract | |
| CN115607467A (en) | A low irritation, whitening and oil control composition containing azelaic acid | |
| CN116687775A (en) | Composition for delaying skin aging, preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |